<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03346863</url>
  </required_header>
  <id_info>
    <org_study_id>PRE-ELECTRIC 2017/1604</org_study_id>
    <nct_id>NCT03346863</nct_id>
  </id_info>
  <brief_title>Predictors for Recurrence of Atrial Fibrillation After Electrical Cardioversion</brief_title>
  <acronym>PRE-ELECTRIC</acronym>
  <official_title>Predictors for Recurrence of Atrial Fibrillation After Electrical Cardioversion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vestre Viken Hospital Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with persistent atrial fibrillation (AF), electrical cardioversion is very
      effective in restoring sinus rhythm if modern, biphasic cardioverters are used. However,
      approximately 50 per cent of the successfully cardioverted patients experience a recurrence
      of AF within a few weeks. Therefore, valid predictors for AF recurrence would be of great
      clinical relevance, to avoid unnecessary procedures.

      In the PRE-ELECTRIC study, we will investigate the predictive value of potential new
      biomarkers with respect to AF recurrence within 30 days after electrical cardioversion. We
      will investigate serum and plasma biomarkers, electrocardiological markers and
      echocardiographic variables in this respect. The study will be undertaken as a prospective
      cohort study at Bærum Hospital, Vestre Viken Hospital Trust, with national and international
      collaborators.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2017</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial fibrillation recurrence</measure>
    <time_frame>30 days after electrical cardioversion</time_frame>
    <description>ECG-documented atrial fibrillation recurrence after successful cardioversion</description>
  </primary_outcome>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Atrial Fibrillation</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, EDTA Plasma, Citrated Plasma, EDTA Whole Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients &gt; 18 years referred for electrical cardioversion for ECG-documented persistent
        atrial fibrillation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years referred for electrical cardioversion for persistent atrial
             fibrillation

          -  Signed, informed consent

        Exclusion Criteria:

          -  Patients &lt; 18 years

          -  Patients with paroxysmal atrial fibrillation

          -  Patients unwilling to participate or without consent competence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arnljot Tveit, MD, PhD</last_name>
    <phone>0047-97171773</phone>
    <email>arnljot.tveit@vestreviken.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mona Olufsen, RN</last_name>
    <phone>0047-90637441</phone>
    <email>mona.olufsen@vestreviken.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bærum Hospital, Vestre Viken</name>
      <address>
        <city>Sandvika</city>
        <state>Bærum</state>
        <zip>1346</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnljot Tveit, MD, PhD</last_name>
      <phone>0047-97171773</phone>
      <email>arnljot.tveit@vestreviken.no</email>
    </contact>
    <contact_backup>
      <last_name>Mona Olufsen, RN</last_name>
      <phone>0047-90637441</phone>
      <email>mona.olufsen@vestreviken.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>November 14, 2017</last_update_submitted>
  <last_update_submitted_qc>November 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electrical Cardioversion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

